Moderna (MRNA) receives full US FDA approval for COVID vaccine, spikevax, in children aged 6months through 11years at increased risk for COVID

10 Jul 2025 - 13:22- Equities- Source: Newswires

EquitiesUS EquitiesMRNAFDAPharmaceuticals, Biotechnology & Life SciencesBiotechnologyModerna IncBiotechnology (Group)S&P 500 IndexNASDAQ 100 IndexUS SessionEU SessionUS SessionEU SessionUnited States

Subscribe Now to Newsquawk

Click here for a 1 week free trial

Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include: